Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

New England Journal of Medicine

Volumn 352, Issue 3, 2005, Pages 225-237

  Bardy, Gust H ^a   Lee, Kerry L ^c   Mark, Daniel B ^c   Poole, Jeanne E ^b   Packer, Douglas L ^d   Boineau, Robin ^e   Domanski, Michael ^e   Troutman, Charles ^a   Anderson, Jill ^a   Johnson, George ^a   McNulty, Steven E ^c   Clapp Channing, Nancy ^c   Davidson Ray, Linda D ^c   Fraulo, Elizabeth S ^c   Fishbein, Daniel P ^b   Luceri, Richard M ^f   Ip, John H ^g  

^a Seattle Institute for Cardiac Research   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DUKE UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f Florida Arrhythmia Consultants   (United States)

^g Ingham Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL; TABLET; TREATMENT OUTCOME;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CAUSE OF DEATH; CROSS-OVER STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; RISK; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 19944429413     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa043399     Document Type: Article

References (18)

1. Singh SN, Flercher RD, Gross Fisher S, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995;333:77-82.
2. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-8.
3. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol 2003;41:1707-12.
4. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8.
5. Moss A, Hall J, Cannom D, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
6. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-84.
7. Connolly SJ, Gent M, Roberts RS, et al. Canadian Impiantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
8. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23.
9. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-82. [Erratum, Lancet 1997;349:1776.]
10. Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-74. [Errata, Lancet 1997;349:1180, 1776.]
11. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT). In: Woosley RL, Singh SN, eds. Arrhythmia treatment and therapy: evaluation of clinical trial evidence. New York: Marcel Dekker, 2000:323-42.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
13. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. 2nd ed. New York: John Wiley, 2002.
14. Cox DR, Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
15. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
16. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
17. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
18. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-75.